Ignite Creation Date:
2024-05-06 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 1:54 PM
Study NCT ID:
NCT04722640
Status:
UNKNOWN
Last Update Posted:
2021-01-29
First Post:
2021-01-20
Brief Title:
Exploring the Effects of IL-23 Inhibition by Risankizumab on Psoriasis Autoimmunity
Sponsor:
Istituto Clinico Humanitas
Organization:
Istituto Clinico Humanitas
Organization Data
Organization:
Istituto Clinico Humanitas
Class:
OTHER
Study ID:
2763
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Istituto Clinico Humanitas
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None